Drug-induced hepatotoxicity: Incidence of abnormal liver function tests consistent with volatile anaesthetic hepatitis in trauma patients

Liver International

Volumn 34, Issue 4, 2014, Pages 576-582

  Lin, Jonathan ^a   Moore, David ^b   Hockey, Brad ^b   Di Lernia, Rachel ^b   Gorelik, Alexandra ^b   Liew, Danny ^b   Nicoll, Amanda ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Anaesthesia; Drug induced liver injury; Inhalation; Liver function tests

Indexed keywords

ALANINE AMINOTRANSFERASE; DESFLURANE; ISOFLURANE; SEVOFLURANE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; EOSINOPHILIA; FEMALE; FEVER; HEPATITIS; HUMAN; JAUNDICE; LIVER FUNCTION TEST; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MEDICAL RECORD REVIEW; RETROSPECTIVE STUDY;

ANAESTHESIA; DRUG-INDUCED LIVER INJURY; INHALATION; LIVER FUNCTION TESTS;

ADULT; ALANINE TRANSAMINASE; ANESTHESIA; ANESTHETICS; DRUG-INDUCED LIVER INJURY; HUMANS; ISOFLURANE; METHYL ETHERS; RETROSPECTIVE STUDIES; RISK FACTORS; STATISTICS, NONPARAMETRIC; VICTORIA; WOUNDS AND INJURIES;

EID: 84895819054     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12278     Document Type: Article

References (23)

1. Reichle FM, Conzen PF. Halogenated inhalational anaesthetics. Best Pract Res Clin Anaesthesiol 2003; 17: 29-46.
2. Bunker JP, Forrest WH, Mosteller F, Vandam LD, eds. The National Halothane Study. A Study of the Possible Association between Halothane Anaesthesia and Postoperative Hepatic Necrosis. Washington: U.S. Government Printing Office, 1969.
3. Eghtesadi-Araghi P, Sohrabpour A, Vahedi H, Saberi-Firoozi M. Halothane hepatitis in Iran: a review of 59 cases. World J Gastroenterol 2008; 14: 5322-6.
4. Martin JL. Volatile anesthetics and liver injury: a clinical update or what every anesthesiologist should know. Can J Anaesth 2005; 52: 125-9.
5. Stachnik J. Inhaled anesthetic agents. Am J Health Syst Pharm 2006; 63: 623-34.
6. Navarro VJ, Senior JR. Drug-related hepatotoxicity. N Engl J Med 2006; 354: 731-9.
7. Aithal GP, Watkins PB, Andrade RJ, et al. Case definition and phenotype standardization in drug-induced liver injury. Clin Pharmacol Ther 2011; 89: 806-15.
8. Danan G, Benichou C. Causality assessment of adverse reactions to drugs - a novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 1993; 46: 1323-30.
9. Teschke R, Frenzel C, Schulze J, Eickhoff A. Herbal hepatotoxicity: challenges and pitfalls of causality assessment methods. World J Gastroenterol 2013; 19: 2864-82.
10. Ray DC, Drummond GB. Halothane hepatitis. Br J Anaesth 1991; 67: 84-99.
11. Jang Y, Kim I. Severe hepatotoxicity after sevoflurane anesthesia in a child with mild renal dysfunction. Paediatr Anaesth 2005; 15: 1140-4.
12. Nicoll A, Moore D, Njoku D, Hockey B. Repeated exposure to modern volatile anaesthetics may cause chronic hepatitis as well as acute liver injury. BMJ Case Rep 2012; 2012: 1-7.
13. Martin JL, Keegan MT, Vasdev GM, et al. Fatal hepatitis associated with isoflurane exposure and CYP2A6 autoantibodies. Anesthesiology 2001; 95: 551-3.
14. Anderson JS, Rose NR, Martin JL, Eger EI, Njoku DB. Desflurane hepatitis associated with hapten and autoantigen-specific IgG4 antibodies. Anesth Analg 2007; 104: 1452-3, Table of contents.
15. Berghaus TM, Baron A, Geier A, et al. Hepatotoxicity following desflurane anesthesia. Hepatology 1999; 29: 613-4.
16. Singhal S, Gray T, Guzman G, Verma A, Anand K. Sevoflurane hepatotoxicity: a case report of sevoflurane hepatic necrosis and review of the literature. Am J Ther 2010; 17: 219-22.
17. Sakaguchi Y, Inaba S, Umeki Y, et al. Retrospective study of post-anesthetic mild liver disorder associated with inhalation anesthetics, halothane and enflurane. J Anesth 1992; 6: 183-91.
18. Chalasani N, Fontana RJ, Bonkovsky HL, et al. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology 2008; 135: 1924-34.
19. Benichou C, Danan G, Flahault A. Causality assessment of adverse reactions to drugs-II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge. J Clin Epidemiol 1993; 46: 1331-6.
20. Kaplowitz N. Causality assessment versus guilt-by-association in drug hepatotoxicity. Hepatology 2001; 33: 308-10.
21. Andrade RJ, Lucena MI, Kaplowitz N, et al. Outcome of acute idiosyncratic drug-induced liver injury: long-term follow-up in a hepatotoxicity registry. Hepatology 2006; 44: 1581-8.
22. Fontana RJ, Watkins PB, Bonkovsky HL, et al. Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct. Drug Saf 2009; 32: 55-68.
23. Njoku D, Laster MJ, Gong DH, et al. Biotransformation of halothane, enflurane, isoflurane, and desflurane to trifluoroacetylated liver proteins: association between protein acylation and hepatic injury. Anesth Analg 1997; 84: 173-8.